---
authors:
- Ebell, Mark H
category: Clinical Review
clinical_significance: High
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/37440751/
file_path: 2023/07/semaglutide-once-weekly-helps-adolescents-lose-weight-but-4.md
issue: '1'
keywords:
- Diabetes Mellitus, Type 2
- Adolescent
- Body Weight
- Humans
- Glucagon-Like Peptides
- Diabetes
- Weight Loss
- Hypoglycemic Agents
last_updated: '2025-07-30'
mesh_terms:
- Humans
- Adolescent
- Hypoglycemic Agents
- Diabetes Mellitus, Type 2
- Glucagon-Like Peptides
- Weight Loss
- Body Weight
original_format: PubMed
pages: Online
patient_population: Pediatric
peer_reviewed: true
pmid: '37440751'
processed_date: '2025-07-30'
publication_date: '2023-07-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-08-09'
reading_time_minutes: 5
source: American family physician
specialty:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: Semaglutide Once Weekly Helps Adolescents Lose Weight, but 4% Developed Acute
  Cholelithiasis.
topics:
- Diabetes Mellitus
- Endocrinology
- Family Medicine
- Metabolic Disorders
volume: '108'
publication_types: &id001
- Journal Article
pubmed_content_enriched: true
pubmed_full_data:
  pmid: '37440751'
  title: Semaglutide Once Weekly Helps Adolescents Lose Weight, but 4% Developed Acute
    Cholelithiasis.
  authors:
  - last_name: Ebell
    fore_name: Mark H
    initials: MH
    affiliation: University of Georgia, Athens, Ga.
  journal_info:
    title: American family physician
    iso_abbreviation: Am Fam Physician
    volume: '108'
    issue: '1'
  publication_info:
    year: '2023'
    month: '07'
    full_date: '2023-07-01'
  article_ids: {}
  mesh_terms:
  - descriptor: Humans
    major_topic: false
  - descriptor: Adolescent
    major_topic: false
  - descriptor: Hypoglycemic Agents
    major_topic: true
  - descriptor: Diabetes Mellitus, Type 2
    major_topic: true
  - descriptor: Glucagon-Like Peptides
    major_topic: false
    qualifiers:
    - qualifier: therapeutic use
      major_topic: false
  - descriptor: Weight Loss
    major_topic: false
  - descriptor: Body Weight
    major_topic: false
  publication_types: *id001
related_articles:
- pmid: '37440751'
  title: Semaglutide Once Weekly Helps Adolescents Lose Weight, but 4% Developed Acute
    Cholelithiasis.
  authors:
  - name: Ebell MH
    authtype: Author
    clusterid: ''
  source: Am Fam Physician
  pubdate: 2023 Jul
- pmid: '34264618'
  title: Once-Weekly Semaglutide Is an Effective Adjunct for Weight Loss in Adults
    without Diabetes Who Are Overweight or Obese.
  authors:
  - name: Slawson DC
    authtype: Author
    clusterid: ''
  source: Am Fam Physician
  pubdate: 2021 Jul 1
- pmid: '32048148'
  title: A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide
    Extended-Release, Dulaglutide and Liraglutide in the UK.
  authors:
  - name: Johansen P
    authtype: Author
    clusterid: ''
  - name: Sandberg A
    authtype: Author
    clusterid: ''
  - name: Capehorn M
    authtype: Author
    clusterid: ''
  source: Adv Ther
  pubdate: 2020 Mar
- pmid: '30875029'
  title: A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide
    Extended-Release and Dulaglutide for Bringing Patients to HbA1c and Weight Loss
    Treatment Targets in the USA.
  authors:
  - name: Johansen P
    authtype: Author
    clusterid: ''
  - name: Hunt B
    authtype: Author
    clusterid: ''
  - name: Iyer NN
    authtype: Author
    clusterid: ''
  - name: Dang-Tan T
    authtype: Author
    clusterid: ''
  - name: Pollock RF
    authtype: Author
    clusterid: ''
  source: Adv Ther
  pubdate: 2019 May
- pmid: '32306244'
  title: Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus
    Once-Daily Liraglutide for the Treatment of TypeÂ 2 Diabetes in the UK.
  authors:
  - name: Johansen P
    authtype: Author
    clusterid: ''
  - name: Chubb B
    authtype: Author
    clusterid: ''
  - name: Hunt B
    authtype: Author
    clusterid: ''
  - name: Malkin SJP
    authtype: Author
    clusterid: ''
  - name: Sandberg A
    authtype: Author
    clusterid: ''
  - name: Capehorn M
    authtype: Author
    clusterid: ''
  source: Adv Ther
  pubdate: 2020 May
---

# Semaglutide Once Weekly Helps Adolescents Lose Weight, but 4% Developed Acute Cholelithiasis.

**Authors:** Ebell, Mark H

**Published in:** American family physician | Vol. 108, No. 1 | 2023-07-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/37440751/)

## Clinical Information

**Population:** Pediatric | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Diabetes Mellitus, Endocrinology, Family Medicine, Metabolic Disorders

## MeSH Terms

Humans, Adolescent, Hypoglycemic Agents, Diabetes Mellitus, Type 2, Glucagon-Like Peptides, Weight Loss, Body Weight

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/37440751/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*
